Amanda Trivino
Nurse Practitioner · Charlotte, NCNPI 1962922575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $421 of the $500 with a category attached, or 84.2%. 8 manufacturers reported payments, led by GSK at 25.0% of the total. Reporting peaked in 2023 at $195 and has fallen 87.6% since, to $24 in 2025.
Across 8 payments — averaging $62.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$125
- Gilead$116
- E.r. Squibb & Sons, L.L.C.$96
- Incyte Corporation$79
- Sanofi-aventis U.S. LLC$26
- Stemline Therapeutics Inc.$24
- plus $35 from 2 others
What the payments were for
- Food & beverage$42184%
- Education$7916%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1 | $125 |
| Gilead | 1 | $116 |
| E.r. Squibb & Sons, L.L.C. | 1 | $96 |
| Incyte Corporation | 1 | $79 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$500 in reported general payments places this provider in the 65th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 62 | $2,979 |
| IpolPoliomyelitis Vaccine, Killed | 16 | $793 |
| Fluconazole | 21 | $659 |
| Daptacel DtapDiph,pertuss(Acell),tet Ped/Pf | 18 | $414 |
| Ondansetron Hcl | 30 | $328 |
| Potassium Chloride | 20 | $239 |
| ActhibHaemoph B Poly Conj-Tet Tox/Pf | 18 | $219 |
| Dexamethasone | 18 | $206 |
| Gabapentin | 14 | $191 |
| Levofloxacin | 25 | $128 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $101 |
| Tramadol Hcl | 12 | $48 |
| Sertraline Hcl | 15 | $32 |
| Prednisone | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Charlotte
- Mary DilorenzoCharlotte$71K
- Dennis TaylorCharlotte$39K
- Geovanna DeeseCharlotte$26K
- Melissa TharpeCharlotte$24K
- Marie MooreCharlotte$21K
- Natasha LaunganiCharlotte$18K
- Vicki MortonCharlotte$18K
- Courtney CarrCharlotte$18K
- Travis ShipeCharlotte$17K
- Kelly XiongCharlotte$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.